See more : Delta Plus Group (0RUJ.L) Income Statement Analysis – Financial Results
Complete financial analysis of Cardlytics, Inc. (CDLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cardlytics, Inc., a leading company in the Advertising Agencies industry within the Communication Services sector.
You may be interested
- Mad Catz Interactive, Inc. (MCZAF) Income Statement Analysis – Financial Results
- Manappuram Finance Limited (MANAPPURAM.BO) Income Statement Analysis – Financial Results
- Hands Corporation Ltd. (143210.KS) Income Statement Analysis – Financial Results
- Shanghai Zijiang Enterprise Group Co., Ltd. (600210.SS) Income Statement Analysis – Financial Results
- TeamViewer AG (TMVWY) Income Statement Analysis – Financial Results
Cardlytics, Inc. (CDLX)
About Cardlytics, Inc.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 309.20M | 298.54M | 267.12M | 186.89M | 210.43M | 150.68M | 130.37M | 112.82M | 77.63M |
| Cost of Revenue | 178.83M | 185.91M | 163.78M | 123.62M | 130.97M | 96.00M | 80.26M | 72.41M | 52.49M |
| Gross Profit | 130.38M | 112.63M | 103.34M | 63.27M | 79.46M | 54.68M | 50.11M | 40.41M | 25.14M |
| Gross Profit Ratio | 42.17% | 37.73% | 38.69% | 33.86% | 37.76% | 36.29% | 38.44% | 35.82% | 32.38% |
| Research & Development | 51.35M | 54.44M | 38.10M | 17.53M | 11.70M | 16.21M | 12.15M | 13.90M | 11.60M |
| General & Administrative | 58.81M | 81.45M | 66.22M | 46.53M | 36.72M | 34.23M | 20.10M | 21.36M | 18.20M |
| Selling & Marketing | 57.43M | 74.75M | 66.00M | 45.31M | 43.83M | 41.88M | 31.93M | 31.26M | 32.78M |
| SG&A | 116.24M | 156.19M | 132.22M | 91.84M | 80.55M | 76.11M | 52.03M | 52.62M | 50.98M |
| Other Expenses | 98.46M | 37.54M | 29.87M | 7.83M | 4.54M | -2.10M | 6.28M | -13.26M | -432.00K |
| Operating Expenses | 266.05M | 248.17M | 200.19M | 117.20M | 96.78M | 95.60M | 67.21M | 70.74M | 64.78M |
| Cost & Expenses | 444.87M | 434.08M | 363.97M | 240.82M | 227.76M | 191.60M | 147.46M | 143.15M | 117.27M |
| Interest Income | 3.85M | 1.44M | 297.00K | 440.00K | 829.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 6.18M | 2.56M | 12.56M | 3.05M | 1.38M | 3.26M | 8.24M | 0.00 | 0.00 |
| Depreciation & Amortization | 29.52M | 43.74M | 33.66M | 12.42M | 7.40M | 3.28M | 3.03M | 4.22M | 2.19M |
| EBITDA | -99.00M | -418.98M | -89.91M | -39.51M | -12.79M | -45.97M | -8.37M | -24.00M | -37.45M |
| EBITDA Ratio | -32.02% | -30.75% | -22.91% | -22.65% | -6.08% | -20.49% | -10.35% | -0.15% | -49.41% |
| Operating Income | -135.67M | -135.54M | -96.85M | -53.92M | -17.33M | -40.92M | -17.10M | -56.23M | -39.64M |
| Operating Income Ratio | -43.88% | -45.40% | -36.26% | -28.85% | -8.23% | -27.15% | -13.12% | -49.84% | -51.06% |
| Total Other Income/Expenses | 968.00K | -8.93M | -13.83M | -1.50M | 181.00K | -12.13M | -2.54M | -19.46M | -1.00M |
| Income Before Tax | -134.70M | -466.71M | -136.43M | -55.42M | -17.14M | -53.04M | -19.64M | -75.70M | -40.64M |
| Income Before Tax Ratio | -43.56% | -156.33% | -51.07% | -29.65% | -8.15% | -35.20% | -15.07% | -67.09% | -52.35% |
| Income Tax Expense | 0.00 | -1.45M | -7.86M | 3.05M | 548.00K | -12.13M | 5.74M | 32.11M | -16.00K |
| Net Income | -134.70M | -465.26M | -128.57M | -58.47M | -17.69M | -53.04M | -19.64M | -75.70M | -40.63M |
| Net Income Ratio | -43.56% | -155.85% | -48.13% | -31.29% | -8.41% | -35.20% | -15.07% | -67.09% | -52.33% |
| EPS | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| EPS Diluted | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| Weighted Avg Shares Out | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
| Weighted Avg Shares Out (Dil) | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK , Sept. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Cardlytics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cardlytics (CDLX)
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Cardlytics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - CDLX
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
Cardlytics Inc May Have Defrauded Investors And Impacted Individuals Can Join The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations...
CDLX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Cardlytics, Inc. investment
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Source: https://incomestatements.info
Category: Stock Reports